The relative responses of neomycins B and C have been determined by a microbiological agar-diffusion method, a turbidimetric method, and by a recently developed gas-liquid-chromatographic (GLC) method capable of separating the neomycin isomers. The ratios of response of neomycin C to neomycin B by the individual methods were as follows: agar-diffusion method, 1:3; turbidimetric method, 1:2.5; and GLC method, 1:1. When neomycin C is assumed to have 35%
Neomycin, as defined in the Code of Federal Regulations (2) , is "each of the antibiotic substances produced by Streptomyces fradiae, and each of the same substances produced by any other means." The antimicrobial components of neomycin ( Fig. 1) include neamine (neomycin A) and neomycins B, C, LPB, and LPc (10; W. S.
Chilton, Ph.D. Thesis, Univ. of Illinois, Urbana, 1963) . The antimicrobial activity of these components drops in the order of neomycin B to C to neamine. Neomycins LPB and LPc possess low antimicrobial activity (W. S. Chilton, 1963) , but data are not available as to their activities in relation to neomycin B, neomycin C, or neamine. Since the ratio of these components varies from lot to lot, the drug content of one particular lot, as determined by the microbiological assay method, depends on the ratio of the components in the sample and the reference standard. Also, the response by a microbiological method to each of these components is quite often variable (10) .
There are several chemical methods which are capable of quantitating neomycins B and C (1, (4) (5) (6) 9) . However, these methods are timeconsuming and are not suitable for a laboratory in which a large number of neomycin products are quantitated routinely. The gas-liquid-chromatographic (GLC) method described by Tsuji and Robertson (12) , on the other hand, enables quantitation of neomycins B and C with greater facility than any other method. gen until they were assayed microbiologically. For the gas chromatographic determination, the neomycin solutions were diluted to 6 mg/ml. One-milliliter amounts of the solutions were pipetted into 1.5-ml serum vials and freeze-dried. The vials were then capped with 13-mm, natural red rubber closures and stored in a desiccator over silica gel until assayed.
Samples were submitted in double blind fashion to each of three analysts and were assayed on 3 consecutive days.
The USP lot I reference standard (767 jug of neomycin base per mg of anhydrous neomycin sulfate) was used to calculate the neomycin content of samples. 
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The merit of the GLC method is its capability of separation and quantitation of neomycins B and C in approximately 30 min (Fig. 2) . The neomycin C content of samples detected by the GLC method is listed in Table 1 . The slight positive bias in the neomycin C content may be due to an incomplete separation of neomycin B and C peaks. The expected responses, as calculated by the following formula, agree well with the responses obtained by the three methods, with the exception of the agar-diffusion method at the 20% neomycin C level.
The expected response equals B f ϫ B r ϩ C f ϫ C r , where B f is the neomycin B fraction of a given sample, B r is the neomycin B response at its 100% level, C r is the neomycin C fraction of a given sample, and C r is the neomycin C response at its 100% level. The coefficient of variation was 1.3% for the GLC method, 1.2% for the turbidimetric method, and 3.9% for the agar-diffusion method.
Quantitative data. The neomycin content of three samples, quantitated by both the GLC and the agar-diffusion methods, is listed in Table 2. The data by the GLC method indicate that these powders contain 9.8, 11.6, and 33.6% of neomycin C; however, neamine, neomycin LP B and neomycin LP C were not detected. From these data, probable microbiological responses were calculated by assuming the antimicrobial activity of neomycin C to be 35% of neomycin B. The calculated microbiological responses thus obtained agree well with values obtained by the agar-diffusion method.
Thus, the GLC method should be a valuable tool for the quantitation of neomycin and for monitoring its biosynthesis and degradation processes.
